Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 46, 2016 - Issue 9
211
Views
25
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Absorption characteristic of paeoniflorin-6′-O-benzene sulfonate (CP-25) in in situ single-pass intestinal perfusion in rats

, , , , , & show all
Pages 775-783 | Received 24 Sep 2015, Accepted 15 Nov 2015, Published online: 29 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chengying Shen, Baode Shen, Junjun Zhu, Jing Wang, Hailong Yuan & Xiaofang Li. (2021) Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Development and Industrial Pharmacy 47:2, pages 207-214.
Read now

Articles from other publishers (23)

Ning Xiao, Feng Xiao, Jinzhang Gao, Zhengkun Xu, Qianlei Wang, Jiajie Kuai, Wei Wei & Chun Wang. (2021) Effects of paeoniflorin‐6′‐O‐benzene sulfonate on the pharmacokinetics, excretion and tissue distribution of leflunomide in rats. Basic & Clinical Pharmacology & Toxicology 130:3, pages 364-374.
Crossref
Ling ZhangYihang ZhangJihong Pan. (2021) Immunopathogenic mechanisms of rheumatoid arthritis and the use of anti-inflammatory drugs. Intractable & Rare Diseases Research 10:3, pages 154-164.
Crossref
Chenchen Han, Yifan Li, Yuwen Zhang, Yang Wang, Dongqian Cui, Tingting Luo, Yu Zhang, Qian Liu, Hao Li, Chun Wang, Dexiang Xu, Yang Ma & Wei Wei. (2021) Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. Acta Pharmaceutica Sinica B 11:7, pages 1835-1852.
Crossref
Xiao‐Yu Cai, Jing‐Ru Ge, Li Xu, Fa‐Qin Liang, Yue Zhu, Yu Tai, Xian‐Zheng Zhang, Jin‐Ling Shu, Dan Mei, Le Han, Chen Wang, Xiao‐Yu Tang, Ling‐Ling Zhang & Wei Wei. (2020) Paeoniflorin‐6′‐o‐benzene sulfonate ( CP ‐25) improves vasculitis through inhibiting IL‐17A / JAK / STAT3 signaling pathway in endothelial cells of HFD CIA rats . Phytotherapy Research 35:2, pages 1033-1047.
Crossref
Xue-zhi Yang & Wei Wei. (2020) CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacologica Sinica 41:11, pages 1387-1394.
Crossref
Jing Zhang, Yang Liu, Ming Long, Jun Li, Weikun Zhao & Qiang Su. (2020) Inhibitory effect of CP-25 on intimal formation and vascular hyperplasia via suppression of GRK2/ERK1/2/EVI1 signaling. Archives of Biochemistry and Biophysics 694, pages 108601.
Crossref
Yongjing Xiang, Qing Zhang, Shujun Wei, Cong Huang, Zhengsheng Li & Yongxiang Gao. (2020) Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities . Journal of Pharmacy and Pharmacology 72:4, pages 483-495.
Crossref
Chen-Chen Han, Qian Liu, Yu Zhang, Yi-Fan Li, Dong-Qian Cui, Ting-Ting Luo, Yu-Wen Zhang, Xin-Ming Wang, Chun Wang, Yang Ma & Wei Wei. (2020) CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4/AC/cAMP/PKA-mediated GRK2 translocation. Clinical Science 134:3, pages 331-347.
Crossref
Hao Tang, Yi-jin Wu, Feng Xiao, Bin Wang, James Asenso, Yong Wang, Wei Sun, Chun Wang & Wei Wei. (2019) Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomedicine & Pharmacotherapy 119, pages 109432.
Crossref
Min Zhang, Mei Gao, Jinyu Chen, Lihua Song & Wei Wei. (2019) CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1/2 signaling in endothelial cells. Molecular Medicine Reports.
Crossref
Mingyi Zhao, Peng Zhou, Jun Yu, Asenso James, Feng Xiao, Chun Wang & Wei Wei. (2018) The tissue distribution and excretion study of paeoniflorin-6′-O-benzene sulfonate (CP-25) in rats. Inflammopharmacology 27:5, pages 969-974.
Crossref
Jin-ling Shu, Xian-zheng Zhang, Le Han, Feng Zhang, Yu-jing Wu, Xiao-yu Tang, Chen Wang, Yu Tai, Qing-tong Wang, Jing-yu Chen, Yan Chang, Hua-xun Wu, Ling-ling Zhang & Wei Wei. (2018) Paeoniflorin-6′-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents. Acta Pharmacologica Sinica 40:6, pages 801-813.
Crossref
James Asenso, Jun Yu, Feng Xiao, Mingyi Zhao, Jian Wang, Yijin Wu, Chun Wang & Wei Wei. (2019) Methotrexate improves the anti-arthritic effects of Paeoniflorin-6'-O-benzene sulfonate by enhancing its pharmacokinetic properties in adjuvant-induced arthritis rats. Biomedicine & Pharmacotherapy 112, pages 108644.
Crossref
Jiajie Tu, Yawei Guo, Wenming Hong, Yilong Fang, Dafei Han, Pengying Zhang, Xinming Wang, Heinrich Körner & Wei Wei. (2019) The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6′-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases. Frontiers in Pharmacology 10.
Crossref
Meng Liu, Jie Yuan, Wen-juan Hu, Chang-qiang Ke, Yi-fan Zhang, Yang Ye, Da-fang Zhong, Guang-rong Zhao, Sheng Yao & Jia Liu. (2018) Pretreatment with broad-spectrum antibiotics alters the pharmacokinetics of major constituents of Shaoyao-Gancao decoction in rats after oral administration. Acta Pharmacologica Sinica 40:2, pages 288-296.
Crossref
Xuezhi Yang, Yingjie Zhao, Xiaoyi Jia, Chun Wang, Yujing Wu, Lingling Zhang, Yan Chang & Wei Wei. (2019) CP-25 combined with MTX/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomedicine & Pharmacotherapy 110, pages 834-843.
Crossref
Yi-jin Wu, Ming-yi Zhao, Jian Wang, Hao Tang, Bin Wang, Feng Xiao, Li-hua Liu, Yun-fang Zhang, Ai-wu Zhou, Chun Wang & Wei Wei. (2018) Absorption and efflux characteristics of CP-25 in plasma and peripheral blood mononuclear cells of rats by UPLC-MS/MS. Biomedicine & Pharmacotherapy 108, pages 1651-1657.
Crossref
Fang Gu, Shixia Xu, Pengying Zhang, Xiaoyun Chen, Yujing Wu, Chun Wang, Mei Gao, Min Si, Xinming Wang, Korner Heinrich, Huaxun Wu & Wei Wei. (2018) CP-25 Alleviates Experimental Sjögren's Syndrome Features in NOD/Ltj Mice and Modulates T Lymphocyte Subsets. Basic & Clinical Pharmacology & Toxicology 123:4, pages 423-434.
Crossref
Jingyu Chen, Ying Wang, Huaxun Wu, Shangxue Yan, Yan Chang & Wei Wei. (2018) A Modified Compound From Paeoniflorin, CP-25, Suppressed Immune Responses and Synovium Inflammation in Collagen-Induced Arthritis Mice. Frontiers in Pharmacology 9.
Crossref
Yang Wang, Chen-chen Han, Dongqian Cui, Ting-ting Luo, Yifan Li, Yuwen Zhang, Yang Ma & Wei Wei. (2018) Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis. Inflammation 41:3, pages 1049-1063.
Crossref
E Zhang, Fulong Chu, Lixu Xu, Hao Liang, Shuliang Song & Aiguo Ji. (2018) Use of fluorescein isothiocyanate isomer I to study the mechanism of intestinal absorption of fucoidan sulfate in vivo and in vitro . Biopharmaceutics & Drug Disposition 39:6, pages 298-307.
Crossref
Feng Zhang, Jin-Ling Shu, Ying Li, Yu-Jing Wu, Xian-Zheng Zhang, Le Han, Xiao-Yu Tang, Chen Wang, Qing-Tong Wang, Jing-Yu Chen, Yan Chang, Hua-Xun Wu, Ling-Ling Zhang & Wei Wei. (2017) CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents. Frontiers in Pharmacology 8.
Crossref
Jun Yu, Feng Xiao, James Asenso, Peng Zhou, Xiao-Dan Yang, Chun Wang & Wei Wei. (2016) Simultaneous determination of paeoniflorin-6′-O-benzene sulfonate (CP-25) and its active paeoniflorin (Pae) metabolite in rat plasma using UPLC-MS/MS: an application for pharmacokinetic studies. RSC Advances 6:114, pages 113209-113218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.